The potential of chitosan for pulmonary drug delivery

Journal of Drug Delivery Science and Technology

Volumn 20, Issue 1, 2010, Pages 33-43

  Grenha, A ^a   Al Qadi, S ^b   Seijo, B ^b   Remunan Lopez C ^b  

^a UNIVERSITY OF ALGARVE   (Portugal)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chitosan; Gene delivery; Microspheres; Nanoparticles; Pulmonary drug administration

Indexed keywords

ALPHA INTERFERON; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; CHITOSAN; CHITOSAN DERIVATIVE; ELCATONIN; FLUORESCEIN ISOTHIOCYANATE; HEPARIN; HYALURONIC ACID; INSULIN; MANNITOL; NANOPARTICLE; OCTREOTIDE; RIFAMPICIN; SALBUTAMOL; TERBUTALINE SULFATE; THEOPHYLLINE;

ASTHMA; CELL VIABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULARY; DRUG SOLUBILITY; HUMAN; NONHUMAN; PNEUMONIA; REVIEW;

EID: 76749099834     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(10)50004-2     Document Type: Review

References (92)

1. Taylor G., Kellaway I. - Pulmonary drug delivery. - In: Drug Delivery and Targeting. For Pharmacists and Pharmaceutical Scientists, A. Hillery, A. Lloyd A., J. Swarbrick Eds., Taylor & Francis, New York, 2001, pp. 269-300.
2. Courrier H.M., Butz N., Vandamme T.F.- Pulmonary drug delivery systems: recent developments and prospects. - Critical Reviews in Therapeutic Drug Carrier Systems, 19, 425-498, 2002.
3. Clark A. - Formulation of proteins and peptides for inhalation. - Drug Delivery Systems & Science, 2, 73-77, 2002.
4. Pandey R., Khuller G.K. - Antitubercular inhaled therapy: opportunities, progress and challenges. - Journal of Antimicrobial Chemotherapy, 55, 430-435, 2005.
5. Grenha A., Carrión-Recio D., Teijeiro-Osorio D., Seijo B., Remuñán-López C. - Nano- and microparticulate carriers for pulmonary drug delivery. - In: Handbook of Particulate Drug Delivery, Vol. 2 (Applications), M.N.V. Kumar Ed., American Scientific Publishers, Valencia, 2008, pp.165-192.
6. Sung J.C, Pulliam B.L, Edwards D.A. - Nanoparticles for drug delivery to the lungs. - Trends in Biotechnology, 25, 563-570, 2007.
7. Jiang W., Kim B.Y., Rutka J.T., Chan W.C. - Advances and challenges of nanotechnology-based drug delivery systems. - Expert Opinion in Drug Delivery, 4, 621-633, 2007.
8. Hirano S., Seino H., Akiyama Y., Nonaka I. - Biocompatibility of chitosan by oral and intravenous administrations. - Polymer Materials and Science Engineering, 59, 897-901, 1988.
9. Lehr C.M., Bouwstra J.A., Schacht E.H., Junginger H.E. - In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. - International Journal of Pharmaceutics, 78, 43-48, 1992.
10. Issa M., Koping-Hoggard M., Artursson P. - Chitosan and the mucosal delivery of biotechnology drugs. - Drug Discovery Today: Technologies, 2, 1-6, 2005.
11. Kurita K. - Chitin and chitosan: functional biopolymers from marine crustaceans. - Marine Biotechnology, 8, 203-226, 2006.
12. Muzzarelli R.A.A. - Chitin. - In: The Polysaccharides, Aspinall G.O. Ed., Academic Press, Orlando, 1985, pp. 417-450.
13. Singh D.K., Ray A.R. - Biomedical applications of chitin, chitosan and their derivatives. - Reviews in Macromolecular Chemistry and Physics, C40, 69-83, 2000.
14. Muzzarelli R.A.A. - Human enzymatic activities related to the therapeutic administration of chitin derivatives. - Cellular and Molecular Life Sciences, 53, 131-140, 1997.
15. Tharanathan R.N., Kittur F.S. - Chitin - the undisputed biomolecule of great potential. - Critical Reviews in Food Science and Nutrition, 43, 61-87, 2003.
16. Dornish M., Hagen A., Hansson E., Peucheur C., Vedier F., Skaugrud O. - Safety of Protasan: ultrapure chitosan salts for biomedical and pharmaceutical use. - In: Advances in Chitin Science., A. Domard, G.A.F. Roberts, K.M., Varum Eds., Jacques Andre Publisher, Lyon, 1997, pp. 664-670.
17. Artursson P., Lindmark T., Davis S.S., Ilium L. - Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). - Pharmaceutical Research, 11, 1358-1361, 1994.
18. Borchard G., Luessen H.L., De Boer G.A., Verhoef J.C., Lehr CM., Junginger H.E. - The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III. Effects of chitosan glutamate and carbomer on epithelial tight junctions in vitro. - Journal of Controlled Release, 39, 131-138, 1996.
19. Fernández-Urrusuno R., Calvo P., Remuñán-López C., Vila-Jato J.L., Alonso M.J. - Enhancement of nasal absorption of insulin using chitosan nanoparticles. - Pharmaceutical Research, 16, 1576-1581, 1999.
20. Fernández-Urrusuno R., Romaní D., Calvo P., Vila-Jato J.L., Alonso M.J. - Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. - S T P Pharma Sciences, 9, 429-436, 1999.
21. DeCampos A., Sánchez A., Alonso M.J. - Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. - International Journal of Pharmaceutics, 224, 159-168, 2001.
22. Yamamoto H., Kuno Y., Sugimoto S., Takeuchi H., Kawashima Y. - Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. - Journal of Controlled Release, 102, 373-381, 2005.
23. Prego C., García-Fuentes M., Torres D., Alonso M.J. - Transmucosal molecular drug delivery. - Journal of Controlled Release, 101, 151-162, 2005.
24. Prego C., Torres D., Alonso M.J. - The potential of chitosan for the oral administration of peptides. - Expert Opinion in Drug Delivery, 2, 843-854, 2005.
25. Cho Y.W., Jang J., Park C.R., Ko S.W. Preparation and solubility in acid and water of partially deacetylated chitins. - Biomacromolecules, 1, 609-614, 2000.
26. Walters D.V. - Lung lining liquid, The hidden depths. - Biology of the Neonate, 81 (Supp. 1), 2-5, 2002.
27. Sieval A.B., Thanou M., Kotzé A.F., Verhoef J.C., Brussee J.C., Junginger H.E. - Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. - Carbohydrate Polymers, 36, 157-165, 1998.
28. Le Dung P., Milas P., Rinaudo M., Desbrières J. - Water soluble derivatives obtained by controlled chemical modifications of chitosan. - Carbohydrate Polymers, 24, 209-214, 1994.
29. Kato Y., Onishi H., Machida Y. - N-succinyl-chitosan as a drug carrier: water-insoluble and water-soluble conjugates. - Biomaterials, 25, 907-915, 2004.
30. Bernkop-Schnurch A., Guggi D., Pinter Y. - Thiolated chitosan: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. - Journal of Controlled Release, 94, 177-186, 2004.
31. Kim T.H., Jiang H.L., Jere D., Park I.K., Cho M.H., Nah J.W., Choi, Y.J., Akaike T., Cho C.S. - Chemical modification of chitosan as a gene carrier in vitro and in vivo. - Progress in Polymer Science, 32, 726-753, 2007.
32. Jin H., Kim T.H., Hwang S.K., Chang S.H., Kim S.K., Chang S.H., Kim H.W., Anderson H.K., Lee H.W., Lee K.H., Colburn N.H., Yang H.S., Cho M.H., Cho M.H., Cho C.S. - Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and aniogenesis in lungs of K-ras null mice. - Molecular Cancer Therapy, 5, 1041-1049, 2006.
33. Sun S., Liu W., Cheng N., Zhang B., Cao Z., Yao K., Liang D., Zuo A., Guo G., Zhang J. - A thermoresponsive chitosan-NIPAAm/vinyl laurate copolymer vector for gene transfection. - Bioconjugate Chemistry, 16, 972-980, 2005.
34. Merwe S.M.V.D., Verhoef J.C., Verheijden J.H.M., Kotzé A.F., Junginger H.E. - Trimethylated chitosan as polymeric absorption enhancer for improved peroral delivery of peptide drugs. - European Journal of Pharmaceutics and Biopharmaceutics, 58, 225-235, 2004.
35. Snyman D., Hamman J.H., Kotzé A.F. - Evaluation of the mucoadhesive properties of N-trimethyl chitosan chloride. - Drug Development and Industrial Pharmacy, 29, 61-69, 2003.
36. Germershaus O., Mao S., Sitterberg J., Bakowsky U., Kissel T. - Gene delivery using chitosan, trimethyl chitosan or polyethyleneglycol-graft- trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro. - Journal of Controlled Release, 125, 145-154, 2007.
37. Hu F., Zhao M., Yuan H., You J., Du Y., Zeng S. - A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. - International Journal of Pharmaceutics, 315, 158-166, 2006.
38. Issa M.M., Köping-Höggard M., Tømmeraas K., Varum K.M., Christensen B.E., Strand S.P., Artursson P. - Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. - Journal of Controlled Release, 115, 103-112, 2006.
39. Kim T.H., Ihm J.E., Choi Y.J., Nah J.W., Cho C.S. - Efficient gene delivery by urocanic acid-modified chitosan. - Journal of Controlled Release, 93, 389-402, 2003.
40. Weers J.G., Tarara T.E., Clark A.R. - Design of fine particles for pulmonary drug delivery. - Expert Opinion on Drug Delivery, 4, 297-313, 2007.
41. Grenha A., Grainger C.I., Dailey L.A., Seijo B., Martin G.P., Remuñán-López C., Forbes B. - Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro. - European Journal of Pharmaceutical Sciences, 31, 73-84, 2007.
42. Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. - Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. - Journal of Controlled Release, 102, 373-381, 2005.
43. Mima S., Miya M., Iwamoto R., Yoshikawa S. - Highly deacetylated chitosan and its properties. - Journal of Applied Polymer Science, 28, 1909-1917, 2003.
44. Hussain A., Arnold J.J., Khan M.A., Ahsan F. - Absorption enhancers in pulmonary protein delivery. - Journal of Controlled Release, 94, 15-24, 2004.
45. Cryan S.A. - Carrier-based strategies for targeting protein and peptide drugs to the lungs. - AAPS Journal, 7, E20-E41, 2005.
46. Takeuchi H., Yamamoto H., Kawashima Y. - Mucoadhesive nanoparticulate systems for peptide drug delivery. - Advanced Drug Delivery Reviews, 47, 39-54, 2001.
47. Lim S.T., Forbes B., Martin G.P., Brown MB. - In vivo and in vitro characterization of novel microparticulates based on hyaluronan and chitosan hydroglutamate. - AAPS PharmsciTech., 2, 14, 2001.
48. Florea B.I., Thanou M., Junginger H.E., Borchard G. - Enhancement of bronchial octreotide absorption by chitosan and N-trimethylchitosan shows linear in vitro/in vivo correlation. - Journal of Controlled Release, 110, 353-361, 2006.
49. Yamada K., Odomi M., Okada N., Fujita T., Yamamoto A. - Chitosan oligomers as potential and safe absorption enhancers for improving the pulmonary absorption of lnterferon-a in rats. - Journal of Pharmaceutical Sciences, 94, 2432-2440, 2005.
50. Huang M., Khor E., Lim L.Y. - Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. - Pharmaceutical Research, 21, 344-353, 2004.
51. Huang Y.C., Vieira A., Huang K.L., Yeh M.K., Chiang CH. J. Pulmonary inflammation caused by chitosan microparticles. - Biomedical Materials Research, 75A, 283-287, 2005.
52. Bivas-Benita M., Van Meijgaarden K.E., Franken K.L.M.C., Junginger H.E., Borchard G., Ottenhoff TH.M., Geluk A. - Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis. - Vaccine, 22, 1609-1615, 2004.
53. Zhang W.F., Zhou H.Y., Chen X.G., Tang S.H., Zhang J.J. - Biocompatibility study of theophylline-cyclodextrin microspheres as pulmonary delivery carriers. - Journal of Materials Science: Materials in Medicine, 20, 1321-1330, 2009.
54. Sivadas N., O'rourke D., Tobin A., Buckley V., Ramtoola Z., Kelly J.G., Hickey A.J., Cryan S.-A. - A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. - International Journal of Pharmaceutics, 358, 159-167, 2008.
55. Singh Dk, Ray AR.- Biomedical applications of chitin, chitosan and their derivatives. - Reviews in Macromolecular Chemistry and Physics, C40, 69-83, 2000.
56. Konstan M.W., Chen P.W., Sherman J.M., Thomassen M.J., Woodm R.E., Boat T.F. - Human lung lysozyme: sources and properties. - American Review of Respiratory Disease, 123, 120-124, 1981.
57. Dai L. - Polymer nanostructures. - In: Encyclopedia of Nanoscience and Nanotechnology, H.S. Nalwa Ed., American Scientific Publishers, 2004, pp. 763-769.
58. Edwards D.A, Ben-Jebria A., Langer R. - Recent advances in pulmonary drug delivery using large, porous inhaled particles. - Journal of Applied Physiology, 84, 379-385, 1998.
59. Edwards D.A., Hanes J., Caponetti G., Hrkach J., Ben-Jebria A., Eskew M.L., Mintzes J., Deaver D., Lotan N., Langer R. - Large porous particles for pulmonary drug delivery. - Science, 276, 1868-1871, 1997.
60. Ben-Jebria A., Chen D., Eskew M.L., Vanbever R., Langer R., Edwards D.A. - Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs - Pharmaceutical Research, 16, 555-61, 1999.
61. Vanbever R., Mintzes J., Wang J., Nice J., Chen D., Batycky R., Langer R., Edwards D.A. - Formulation and physical characterization of large porous particles for inhalation. - Pharmaceutical Research, 16, 1735-1742, 1999.
62. Dunbar C., Scheuch G., Sommerer K., Delong M., Verma A., Batycky R.- In vitro and in vivo dose delivery characteristics o large porous particles for inhalation. - International Journal of Pharmaceutics, 245, 179-189, 2002.
63. Seville P.C., Li H-Y. Learoyd T.P. - Spray-dried powders for pulmonary drug delivery. - Critical ReviewsTM in Therapeutic Drug Carrier Systems, 24, 307-360, 2008.
64. Vehring R. - Pharmaceutical particle engineering viaspray drying (Expert Review). - Pharmaceutical Research, 25, 9999-1022, 2008.
65. Williams R.O., Barron M.K., Alonso M.J., Remuñan-Lopez C. - Investigation of a pMDIsystem containing chitosan microspheres and P134a. - International Journal of Pharmaceutics, 174, 209-222, 1998.
66. Huang Y.C., Yeh M.K., Chiang C.H - Formulation factors in preparing BTM-chitosan microspheres by spray drying method. - International Journal of Pharmaceutics, 242, 239-242, 2002.
67. Huang Y.C., Yeh M.K., Cheng S.N., Chiang C.H. - The characteristics of betamethasone-loaded chitosan microparticles by spray-drying method. - Journal of Microencapsulation, 20, 459-472, 2003.
68. Learoyd T.P., Burrows J.L., French E., Seville P.C. - Sustained delivery by leucine-modified chitosan spray-dried respirable powders. - International Journal of Pharmaceutics, 372, 97-104, 2009.
69. Corrigan D.O., Healy A.M., Corrigan O.I. - Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. - European Journal of Pharmaceutics and Biopharmaceutics, 62, 295-305, 2006.
70. Chan H.K., Clark A., Gonda I., Mumenthaler M., Hsu C. - Spray dried powders and powder blends of recombinant human deoxyribonuclease (rhDNase) for aerosol delivery. - Pharm. Respir., 14, 431-437, 1997.
71. Bosquillon C., Lombry C., Preat V., Vanbever R. - Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. - Journal of Controlled Release, 70, 329-339, 2001.
72. Zhang W., Chen X., Li P., He Q., Zhou H., Cha D.- Chitosan and β-cyclodextrin microspheres as pulmonary sustained delivery systems. - Journal of Wuhan University of Technology, Materials Science Edition, 23, 541-546, 2008.
73. Pandit S., Martin, C., Alpar H.O. - Positively charged rifampicin-based microspheres for lung delivery. - Journal of Drug Delivery Science and Technology, 15, 281-287, 2005.
74. Manca M.L., Mourtas S., Dracopoulos V., Fadda A.M., Antimisiaris S.G. - PLGA, chitosan or chitosan-coated PLGA microparticles for alveolar delivery? A comparative study of particle stability during nebulization. - Colloids and Surfaces B: Biointerfaces, 62, 220-231, 2008.
75. Manca M.L., Loy G., Zaru M., Fadda A.M., Antimisiaris S.G. - Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. - Colloids and Surfaces B: Biointerfaces, 67, 166-170, 2008.
76. Calvo P., Remuñan-Lopez C., Vila-Jato J.L., Alonso M.J. - Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. - Journal of Applied Polymer Science, 63, 125-132, 1998.
77. Calvo P., Remuñán-López C., Vila-Jato J.L., Alonso M.J. - Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. - Pharmaceutical Research, 14, 1431-1436, 1997.
78. Oyarzun-Ampuero F.A., Brea J., Loza M.I., Torres D., Alonso M.J. - Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. - International Journal of Pharmaceutics, 381, 122-129, 2009.
79. Teijeiro-Osorio D., Remunán-López C., Alonso M.J. - New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. - Biomacromolecules, 10, 243-249, 2009.
80. Teijeiro-Osorio D., Remunán-López C., Alonso M.J. - Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. - European Journal of Pharmaceutics and Biopharmaceutics, 71, 257-263, 2009.
81. Cryan S.A., Holohan A., Donohue R., Darcy R., O' Driscoll C.M. - Cell transfection with polycationic cyclodextrin vectors. - European Journal of Pharmaceutical Sciences, 21, 625-633, 2004.
82. Challa R., Ahuja A., Ali J., Khar R.K. - Cyclodextrins in drug delivery: an updated review - AAPS PharmSciTech, 6, E329-E357, 2005.
83. Arima H., Kihara F., Hirayama F., Uekema K. - Enhancement of gene expression by polyamidoamine dendrimer conjugates with alpha-, beta and gamma-cyclodextrins. - Bioconjugate Chemistry, 12, 476-484, 2001.
84. Hwang S.J., Bellocq N.C., Davis M.E. - Effects of structure of beta-cyclodextrin containing polymers on gene delivery - Bio-conjugate Chemistry, 12, 280-290, 2001.
85. Forrest M.L., Gabrielson N., Pack D.W. - Cyclodextrin-polyethylenimine conjugates for targeted in vitro gene delivery. - Biotechnology and Bioengineering, 89, 416-423, 2005.
86. Csaba N., Koping-Hoggard M., Fernández-Mejía E., Novoa-Carballal R., Riguera R., Alonso M.J. - Ionically cross-linked chitosan nanoparticles as gene delivery systems: effect of PEGylation on in vitro and in vivo gene transfer. - Journal of Biomedical Nanotechnology, 5, 162-1671, 2009.
87. De La Fuente M., Seijo B., Alonso M.J. - Design of novel polysaccharide nanostructures for gene delivery. - Nanotechnology, 19, 0751065 (9 p), 2008.
88. Li X.W., Lee D.K.L., Chan A.S.C., Alpar H.O. - Sustained expression in mammalian cells with DNA complexes and chitosan nanoparticles. - Biochim. Biophys. Acta, 1630, 7-18, 2003.
89. Surendrakumar K., Martin G.P., Hodgers E.C.M., Jansen M., Blair J.A. - Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. - Journal of Controlled Release, 91, 385-394, 2003.
90. Grenha A., Seijo B., Remuñan-Lopez C. - Microencapsulated chitosan nanoparticles for lung protein delivery. - European Journal of Pharmaceutical Sciences, 25, 427-437, 2005.
91. Grenha A., Seijo B., Serra C., Remuñán-López C. - Chitosan nanoparticle-loaded mannitol microspheres: structure and surface characterisation. - Biomacromolecules, 8, 2072-2079, 2006.
92. th International Conference of the European Chitin Society, Venice, Italy 23-26 May 2009.